Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velzatinib in Advanced Gastrointestinal Stromal Tumors (StrateGIST J)
NCT07689201Phase 2Recruiting
- Sponsor
- GSK
- Start
- Aug 2026
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
A Phase 2 trial of velzatinib in gastrointestinal stromal tumor (GIST), sponsored by GSK. Started Aug 2026; status: recruiting.
02
Drugs
velzatinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT07689201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07689201.